QuestionsQuestions (BFAD BUREAU MEMORANDUM NO. 8, S. 2000)
The memorandum states that all labelling claims must be consistent with the definition of cosmetics provided by RA 7394 (amending RA 3720). Thus, the basis is RA 7394 and its amendment to RA 3720.
All labelling claims must be substantiated by scientific evidence and/or by the cosmetic formulation or preparation itself.
It requires that labelling claims be consistent with the definition of cosmetics under RA 7394 (amending RA 3720).
BFAD said the Joint BFAD-Industry Task Force carefully deliberated and recommended the revised claims.
Technical justifications for these claims must be submitted.
It states that claims not permissible under Bureau Memorandum No. 21, s. 1995 may now be allowed, because they have been revised.
The permissible claims under “Anti-wrinkle” include: (1) Helps prevent formation of wrinkles; (2) Helps prevent stretch marks; and (3) Removes, sheds off dead skin cells.
The memorandum text provided indicates the heading “Contouring/Body contouring,” but the specific claim lines are not shown in the excerpt.
It sets a compliance requirement: even if a claim is categorized as permissible by the memorandum, the manufacturer/distributor must still be able to justify it technically (and earlier sections require scientific substantiation).
They must ensure that any labeling claims are substantiated by scientific evidence and/or supported by the cosmetic formulation, consistent with the statutory definition of cosmetics.
BFAD can revise what claims are permissible through deliberation with industry (via a Joint Task Force), and claims previously not permissible may be allowed after revision and submission of technical justifications.
The label claim must be substantiated by scientific evidence and/or by the formulation itself, and technical justifications must be submitted to support the specific claim.
There is still a requirement. Even though the claims are “considered permissible,” the memorandum conditions permissibility on the submission of technical justifications (and earlier it requires substantiation by scientific evidence/formulation).
It states: “This shall take effect immediately.”
It was signed by WILLIAM D. TORRES, PH.D., identified as Director.